A longitudinal study of Apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults

American Journal of Geriatric Psychiatry

Volumn 8, Issue 3, 2000, Pages 196-200

  Mauricio, Maritess ^b   O'Hara, Ruth ^b   Yesavage, Jerome A ^b   Friedman, Leah ^b   Kraemer, Helena C ^b   Van De Water, Margaret ^b   Murphy Jr , Greer M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; DEMENTIA; DEPRESSION; FEMALE; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; RATING SCALE; RISK FACTOR; SCORING SYSTEM;

EID: 0033949530     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200008000-00003     Document Type: Article

References (36)

1. McGuire MH, Rabins PV: Mood disorders, in Textbook of Geriatric Neuropsychiatry, 1st Edition. Edited by Coffey CE, Cummings JL. Washington DC, American Psychiatric Press, 1994, pp 243-260
2. Raskind MA: The clinical interface of depression and dementia. J Clin Psychiatry 1998; 59(suppl 10):9-12
3. Speck CE, Kukull WA, Brenner DE, et al: History of depression as a risk factor for Alzheimer's disease. Epidemiology 1995; 6:366-369
4. Devanand DP, Sano M, Tang MX, et al: Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996; 53:175-182
5. Corder EH, Saunders AM, Strittmatter WJ, et al: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993; 261:921-923
6. Roses AD, Saunders AM: APOE is a major susceptibility gene for Alzheimer's disease. Curr Opin Biotechnology 1994; 5:663-667
7. Hyman B, Gomez-Isla T, Briggs M, et al: Apolipoprotein-E and cognitive change in an elderly population. Ann Neurol 1996; 40:55-66
8. O'Hara R, Yesavage JA, Kraemer HC, et al: The APOE ε4 allele is associated with decline on delayed recall performance in community-dwelling older adults. J Am Geriatr Soc 1998; 46:1493-1498
9. Small BJ, Basun H, Backman L: Three-year changes in cognitive performance as a function of apolipoprotein-E genotype: evidence from very old adults without dementia. Psychol Aging 1998; 13:80-87
10. Roses AD: Genetic testing for Alzheimer's disease: practical and ethical issues. Arch Neurol 1997; 54:1226-1229
11. McConnell LM, Koenig BA, Greely HT, et al: Genetic testing and Alzheimer's disease: has the time come? Nature Med 1998; 4:757-759
12. Bird TD: Apolipoprotein-E genotyping in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol 1995; 38:2-3
13. Krishnan KR, Tupler LA, Ritchie JC Jr, et al: Apolipoprotein-E ε4 frequency in geriatric depression. Biol Psychiatry 1996; 40:69-71
14. Heidrich A, Thome J, Rosier M, et al: Apolipoprotein-E ε4 allele frequency in late-onset depression. Biol Psychiatry 1997; 80:912-913
15. Zubenko GS, Henderson R, Stiffler S, et al: Association of the APOE ε4 allele with clinical subtypes of late-life depression. Biol Psychiatry 1996; 40:1008-1016
16. Ramachandran G, Marder K, Tang M, et al: A preliminary study of apolipoprotein-E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 1996; 47:256-259
17. Lopez OL, Kamboh MI, Becker JT, et al: The apolipoprotein-E ε4 is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology 1997; 49:794-797
18. Lysketsos CG, Baker L, Warren A, et al: Depressions, delusions, and hallucination in Alzheimer's disease: no relationship to apolipoprotein-E genotype. J Neuropsychiatry Clin Neurosci 1997; 9:64-67
19. Cacabelos R, Rodriguez B, Carrera C, et al: APOE-related frequency of cognitive and noncognitive symptoms in dementia. Methods Find Exp Clin Pharmacol 1996; 18:693-706
20. Cantillon M, Harwood D, Barker W, et al: No association between apolipoprotein-E genotype and late-onset depression in Alzheimer's disease. Biol Psychiatry 1997; 41:246-248
21. Holmes C, Levy R, McLoughlin DM, et al: Apolipoprotein-E: non-cognitive symptoms and cognitive decline in late-onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996; 61:580-583
22. Holmes C, Russ C, Kirov G, et al: Apolipoprotein-E, depressive illness, depressive symptoms, and Alzheimer's disease. Biol Psychiatry 1998; 43:159-164
23. Class CA, Unverzagt FW, Gao S, et al: The association between APOE genotype and depressive symptoms in elderly African American subjects. Am J Geriatr Psychiatry 1997; 5:339-343
24. Forsell Y, Corder EH, Basun H, et al: Depression and dementia in relation to apolipoprotein-E polymorphism in a population sample age 75+. Biol Psychiatry 1997; 42:898-903
25. Schmand B, Hooijer C, Jonker C, et al: Apolipoprotein-E phenotype is not related to late-life depression in a population-based sample. Soc Psychiatry Epidemiol 1998; 33:21-26
26. Folstein MF, Folstein SE, McHugh PH: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
27. Yesavage JA, Brink TL, Rose TL, et ai: Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983; 17:37-49
28. Hixon JE, Vernier DT: Restriction isotyping of human apolipoprotein-E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31:545-548
29. Murphy GM Jr, Taylor J, Kraemer HC, et al: No association between apolipoprotein-E ε4 allele and rate of decline in Alzheimer's disease. Am J Psychiatry 1997; 154:603-608
30. Toner J, Gurland B, Teresis J: Comparison of self-administered and rater-administered methods of assessing levels of severity of depression in elderly patients. J Gerontol 1988; 43:136-140
31. Petersen RC, Smith GE, Waring SC, et al: Aging, memory, and mild cognitive impairment. Int Psychogeriatr 1997; 9(suppl 1):65-69
32. Migliorelli R, Teson A, Sabe L, et al: Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease. Am J Psychiatry 1995; 152:37-44
33. DesRosiers G, Hodges JR, Berrios G: The neuropsychological differentiation of patients with very mild Alzheimer's disease and/or major depression. J Am Geriatr Soc 1995; 43:1256-1263
34. Nelson DV, Harper RG, Kotik-Harper D, et al: Brief neuropsychologic differentiation of demented vs. depressed elderly inpatients. Gen Hosp Psychiatry 1993; 15:409-416
35. Farrer L, Brin MF, Elsas L, et al: Statement on use of apolipoprotein-E testing for Alzheimer's disease. American College of Medical Genetics/American Society of Human Genetics Working Group on APOE and Alzheimer's Disease. JAMA 1995; 274:1627-1629
36. Tanzi R, Breitner J, Farrer L, et al: Apolipoprotein-E genotyping in Alzheimer's disease. National Institute on Aging/Alzheimer's Association Working Group. Lancet 1996; 347:1091-1095